CCS and hepatocellular carcinoma: We described above that the dose-dependent increases in CCS levels were accompanied by dose-dependent decreases in Madcam1 levels in HCC cells treated with increasing concentrations of Doxo (Figure 1A and Supplementary Figure 1A).